Standout Papers

<i>PD-L1</i> and <i>PD-L2</i> Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outco... 2016 2026 2019 2022 546
  1. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome (2016)
    Margaretha G.M. Roemer, Ranjana H. Advani et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Natural killer cell therapies
2024 StandoutNature
1 intermediate paper

Works of Sarah E. Daadi being referenced

Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
2016 Standout

Author Peers

Author Last Decade Papers Cites
Sarah E. Daadi 587 652 74 346 9 842
Courtney Connelly 503 663 73 398 13 878
Won-Seog Kim 674 564 41 243 8 774
Margaretha G.M. Roemer 541 680 85 380 18 937
Lawrence M. Weiss 433 523 108 154 12 916
Eleni Diamandidou 512 308 44 319 7 950
TC Greiner 699 446 77 175 9 812
Allison Crosby‐Thompson 653 383 148 144 10 864
Cosimo G. Sciotto 333 517 41 190 11 805
Rosita L. ten Berge 429 277 54 232 18 710
Iris Hamlin 494 414 136 178 11 926

All Works

Loading papers...

Rankless by CCL
2026